X0206 3 2021-02-04 0 0001817229 Vor Biopharma Inc. VOR 0001842523 Jorgensen Nathan D. C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 400 CAMBRIDGE MA 02140 0 1 0 0 Chief Financial Officer Common Stock 25735 D Series B Preferred Stock Common Stock 3534 D Employee Stock Option (right to buy) 1.90 2030-08-24 Common Stock 115578 D Employee Stock Option (right to buy) 1.90 2030-08-20 Common Stock 135514 D Each share of Series B Preferred Stock is convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 13.6-for-one basis, has no expiration date and will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering. 1/4th of the shares underlying the option vest on May 22, 2021, with the remainder vesting in equal monthly installments over 3 years, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date. 11/48ths of the shares underlying the option vest on June 1, 2021, with the remainder vesting in equal monthly installments over 37 months, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date. Exhibit List - Exhibit 24 - Power of Attorney /s/ Jason Minio, Attorney-in-Fact 2021-02-04